Weakness found in deadly malaria parasite

Sanger Institute researchers in Cambridge have identified the route that plasmodium falciparum--the most deadly of the malaria parasites--uses to enter red blood cells. By interrupting red blood cell receptor basigin and PfRh5, a protein on the parasite, the Sanger team was able to prevent infection. The findings, which were published in the journal Nature, could serve as a basis for a vaccine that trains the body to attack PfRh5. Report

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.